The drug 'Eufillin' (pills). Instructions for use

The medicine "Eufillin" is widely used in medical practice. In particular, the drug is prescribed for cardiovascular, pulmonary pathologies. Effective means for circulatory disorders.

Characterizing the drug "Eufillin" (tablets), the instruction for use indicates its ability to expand the vessels, improving their permeability.

In the treatment of lung diseases, the medication facilitates the separation of sputum, effectively relieves dyspnea. The drug "Eufillin" is recommended to use to relieve bronchospasm. The agent is able to affect the muscles of the respiratory organs, reducing the contractility. The drug "Eufillin" is effective for the removal of spasms not only in the bronchi, but also blood vessels, as well as bile ducts.

The drug has the ability to suspend the transport of calcium ions through the channels of cell membranes.

The drug "Eufillin" (tablets), the instruction for use indicates this, has a moderate diuretic (diuretic) effect, reduces platelet aggregation. The medication has a stimulating effect on the respiratory center, increases the strength and frequency of heart contractions.

Biological availability of the drug for oral administration is eighty-one hundred percent. The drug is approximately 60% bound to plasma proteins. Means "Eufillin" (tablets), the instruction for use contains such information, almost completely (by ninety percent) is metabolized in the liver. The half-life is from five hours to one day.

Means "Eufillin" (tablets) instruction for use recommends bronchial obstructive syndrome, frustration of the respiratory center. As part of the combined treatment, medication is prescribed in case of circulatory insufficiency and cerebral blood supply disorders.

The dosage is set individually. Typically, during the day, three to four times for one or two tablets of "Eufillin" are recommended. If necessary (as prescribed by the doctor), the dosage may be increased at intervals of two to three days before the required therapeutic efficacy is achieved.

When using the drug, a decrease in appetite is likely. There may be a headache, nausea, tachycardia, vomiting, heart rhythm disorder , albuminuria. In a number of cases, on the background of taking the medication, hematuria was noted. Probable side effects are allergic reactions (rash or itching). In rare cases, hypoglycemia, exacerbation of the ulcer, convulsive condition may occur.

Means "Eufillin" is contraindicated in angina pectoris, acute heart failure, heart rhythm disorders, epilepsy. The drug is not recommended for violations in the activity of the kidney or liver of a marked nature, hypersensitivity to aminophylline.

Caution should be observed when prescribing "Eufillin" to patients with a fever of an unclear nature, to patients in old age.

It is established that the drug can increase the urinary acid content in urine.

Use of the drug "Eufillin" during gestation and feeding is allowed only on indications. In this case, the appointment is made only by a doctor. The specialist should monitor the condition of pregnant and nursing patients during the entire therapeutic course.

With the simultaneous use of the drug "Eufillin" with drugs "Salbutamol" and "Terbutaline" their bronchodilating activity is increased.

Combined use of a drug with beta-blockers can provoke bronchospasm.

Means "Eufillin". Form of issue

The drug is in the form of a solution for injection (both intravenous and intramuscular). Tablets and candles "Eufillin" are produced.

Before using the drug should consult a doctor.